Cargando…
Iopromide for Contrast-Enhanced Mammography: A Systemic Review and Meta-Analysis of Pertinent Literature
BACKGROUND: Contrast-enhanced mammography (CEM) is an emerging breast imaging modality. Clinical data is scarce. OBJECTIVES: To summarize clinical evidence on the use of iopromide in CEM for the detection or by systematically analyzing the available literature on efficacy and safety. DESIGN: Systema...
Autores principales: | Endrikat, Jan, Khater, Hassan, Boreham, Alexander DP, Fritze, Sabine, Schwenke, Carsten, Bhatti, Aasia, Trnkova, Zuzana Jirakova, Seidensticker, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433886/ https://www.ncbi.nlm.nih.gov/pubmed/37600467 http://dx.doi.org/10.1177/11782234231189467 |
Ejemplares similares
-
Marking Techniques for Targeted Axillary Dissection Among Patients
With Node-Positive Breast Cancer Treated With Neoadjuvant
Chemotherapy
por: Gante, Inês, et al.
Publicado: (2023) -
Hormone Receptor-Positive / HER2-Negative Early Breast Cancer High-Risk Population: An Algorithm for Optimization Systemic Adjuvant Treatment Based on 2022 Updates
por: González-Hurtado, Daniel, et al.
Publicado: (2023) -
Risk of Hypersensitivity Reactions to Iopromide in Children and Elderly: An Analysis of 132,850 Patients From 4 Observational Studies and Pharmacovigilance Covering >288 Million Administrations
por: Endrikat, Jan, et al.
Publicado: (2022) -
Sensitivity of Contrast-Enhanced Breast MRI vs X-ray Mammography Based on Cancer Histology, Tumor Grading, Receptor Status, and Molecular Subtype: A Supplemental Analysis of 2 Large Phase III Studies
por: Endrikat, Jan, et al.
Publicado: (2022) -
Towards clinical grating-interferometry mammography
por: Arboleda, Carolina, et al.
Publicado: (2019)